REVENUE MEMORANDUM CIRCULAR NO. 58-2022 issued on April 27, 2022 publishes the March 10, 2022 letter from Food and Drug Administration OIC-Director General, Dr. Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act). The List corrects the names of certain medicines for hypertension and COVID-19 treatment.